RecruitingNCT00991094
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
Data Collection to Assess Acute and Late Normal Tissue Sequelae in Proton Therapy for Adults
Sponsor
M.D. Anderson Cancer Center
Enrollment
5,000 participants
Start Date
May 27, 2005
Study Type
OBSERVATIONAL
Conditions
Summary
This study collects information on the side effects of proton therapy and detailed information on the proton therapy treatment plan itself. This may help researchers develop methods to predict the risk of side effects for future patients and learn the long-term benefit of proton therapy.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- All patients scheduled for radiation treatment with protons at UTMDACC are eligible for this protocol
- Patients must sign a study-specific consent form prior to study entry
Exclusion Criteria1
- Patients who are unable or unwilling to attend the required periodic follow-ups either at M.D. Anderson or at a different site
Interventions
OTHERQuality-of-Life Assessment
Complete questionnaires
OTHERQuestionnaire Administration
Complete questionnaires
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT00991094
Related Trials
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
NCT06418204467 locations
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
NCT0618475011 locations
National Cancer Institute "Cancer Moonshot Biobank"
NCT04314401152 locations
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
NCT059415204 locations
The Vanguard Study: Testing a New Way to Screen for Cancer
NCT0699589836 locations